Stay updated on MUKnineb: OPTIMUM Treatment Protocol Clinical Trial
Sign up to get notified when there's something new on the MUKnineb: OPTIMUM Treatment Protocol Clinical Trial page.

Latest updates to the MUKnineb: OPTIMUM Treatment Protocol Clinical Trial page
- Check4 days agoChange DetectedThe page no longer references 'Multiple myeloma' and 'MedlinePlus Genetics' under related topics. This reduces disease-specific context on the study detail page.SummaryDifference0.1%

- Check12 days agoChange DetectedAdded related topics including Multiple myeloma and MedlinePlus Genetics and updated PubMed publication notes to indicate automatic population (Revision: v3.3.2); removed the previous PubMed note (Revision: v3.2.0).SummaryDifference0.2%

- Check19 days agoChange DetectedRemoved the general government funding/status notice from the page. All study content (title, identifiers, sponsor, locations, eligibility criteria, and outcomes) remains unchanged.SummaryDifference0.3%

- Check26 days agoChange DetectedRemoved related-topic links for 'Multiple Myeloma' and 'MedlinePlus Genetics' from the Related Topics section; this change does not affect core trial details such as condition, interventions, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check34 days agoChange DetectedRemoved the Related Topics entries 'Multiple myeloma' and 'MedlinePlus Genetics' from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedNo additions or deletions were detected on the Study Details page for NCT03188172; the study information remains as listed.SummaryDifference0.3%

Stay in the know with updates to MUKnineb: OPTIMUM Treatment Protocol Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MUKnineb: OPTIMUM Treatment Protocol Clinical Trial page.